Low HDL-C levels are commonly associated with increasing a person's risk of developing cardiovascular disease. However, a new study in the Journal of the American College of Cardiology suggests this may not be the case for all patient populations. 

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial. 

The ACC is especially excited to see what VR training can do to bring minimally invasive interventional procedures to more and more patients throughout the United States.

Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

However, researchers noted, there is still considerable room for improvement.

The risk of developing vaccine-related myocarditis, pericarditis or myopericarditis remains very low, researchers wrote. 

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

In the first few weeks of open enrollment, new signups on the healthcare marketplace, healthcare.gov, are up nearly 40%, according to the Department of Health and Human Services (HHS).

The regions that displayed the most significant differentiations in susceptibility values are known to be associated with neurological conditions such as fatigue, insomnia, anxiety, depression, headaches and other cognitive issues—all common complaints among many COVID long haulers.